Skip to content

Enterprise value at other companies

CVS Health logo
CVS HealthCVS
$96.84B+4.3%
Amazon logo
AmazonAMZN
$2.37T+12.5%
Doximity logo
DoximityDOCS
$4.09B-61.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$6.34B+33.4%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$10B+71.5%
Cencora logo
CencoraCOR
$71.12B+20.6%

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-43.1%
P/E45.5×-12.3×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s enterprise value?
GoodRx Holdings, Inc. (GDRX) reported enterprise value of $977.09M in Q1 2026.
How has GoodRx Holdings, Inc.'s enterprise value changed year-over-year?
GoodRx Holdings, Inc.'s enterprise value decreased by 49.4% year-over-year, from $1.93B to $977.09M.
What is the long-term trend for GoodRx Holdings, Inc.'s enterprise value?
Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s enterprise value has grown at a -40.5% compound annual growth rate (CAGR), from $16.12B to $1.2B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.